Genetically Engineered Babies Are Banned. Tech Titans Are Trying to Make One Anyway.
By Emily Glazer, Katherine Long, Amy Dockser Marcus,
The Wall Street Journal
| 11. 08. 2025
Startups funded by some of the most powerful billionaires in Silicon Valley are pushing the boundaries of reproductive genetics, hoping to prevent diseases as well as improve the chances for a high IQ and other preferred traits
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called Preventive—has been quietly preparing what would amount to a biological first. They are working toward creating a child born from an embryo edited to prevent a hereditary disease. In recent months, executives at the company privately said a couple with a genetic disease had been identified who was interested in participating, according to people familiar with the conversations.
Gene-editing technologies now in use for treatment after birth allow scientists to cut, edit and insert DNA, but using the process in sperm, eggs or embryos is far more controversial and has prompted calls by scientists for a global moratorium until the ethical and scientific questions get resolved. Editing genes in embryos with the intention of creating babies from them is banned in the U.S. and many countries.
Preventive has been searching for places to experiment where embryo editing is allowed, including...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...